Liu Denghui,Li Ming,Tang Xianglian,et al.Diagnosis and treatment of inflammatory myofibroblastic tumor of gastrointestinal tract in children[J].Journal of Clinical Pediatric Surgery,2024,(02):178-183.[doi:10.3760/cma.j.cn101785-202308019-015]
儿童胃肠道炎性肌纤维母细胞瘤的诊断与治疗
- Title:
- Diagnosis and treatment of inflammatory myofibroblastic tumor of gastrointestinal tract in children
- Keywords:
- Neoplasms; Muscle Tissue; Gastrointestinal Neoplasms; Inflammation; Diagnosis; Therapy; Prognosis; Child
- 摘要:
- 目的 总结儿童胃肠道炎性肌纤维母细胞瘤(inflammatory myofibroblastic tumor,IMT)的临床特征及诊治经验。方法 回顾性分析湖南省儿童医院普外科2010年1月至2021年12月收治的11例胃肠道IMT患儿临床资料,男7例,女4例;发病年龄8个月至15岁,收集患儿临床特点、影像学检查、病理学诊断、外科治疗及随访情况等。结果 11例主要以腹痛、呕吐、发热、血便及腹部肿物就诊。10例行一期手术完整切除肿瘤,其中1例术后予化疗;1例经活检确诊后未予手术,仅行化疗。11例均病理诊断明确,均获随访(随访时间6~60个月),其中9例治愈,2例带瘤生存(1例于术后2年复发)。结论 儿童胃肠道IMT临床少见,手术是首选治疗方法。复发、难治性IMT的治疗亟待进一步积累经验。
- Abstract:
- Objective To summarize the clinical characteristics and treatment experience of gastrointestinal inflammatory myofibroblastic tumor (IMT) in children.Methods From January 2010 to December 2021,retrospective analysis was performed for the relevant clinical data of 11 children of abdominal gastrointestinal IMT.Clinical manifestations,radiographic features,pathological examinations,surgical approaches and follow-up results were recorded.And the related literatures of pediatric abdominal inflammatory myofibroblastic tumors were retrieved.Results There were 7 boys and 4 girls with a median onset age of 56(8-180) months.The major symptoms were abdominal pain,vomiting,fever,bloody stool and abdominal lump.Total resection (n=10) was performed and postoperative chemotherapy (n=1) offered.And one child underwent biopsy plus postoperative chemotherapy.The follow-up period was (6-60) months until December 2022.Nine children were cured and 2 cases survived with tumors.One child recurred at 2 years post-operation.Conclusions The incidence of gastrointestinal IMT in children is rare.Surgery is a preferred option.Proper managements of recurrent and refractory IMT require extensive experiences and further researches.
参考文献/References:
[1] Gros L,Dei Tos AP,Jones RL,et al.Inflammatory myofibroblastic tumour:state of the art[J].Cancers (Basel),2022,14(15):3662.DOI:10.3390/cancers14153662.
[2] Brunn H.Two interesting benign lung tumors of contradictory histopathology:remarks on the necessity for maintaining the chest tumor registry[J].J Thorac Surg,1939,9(2):119-131.DOI:10.1016/S0096-5588(20)32030-4.
[3] Surabhi VR,Chua S,Patel RP,et al.Inflammatory myofibroblastic tumors:current update[J].Radiol Clin North Am,2016,54(3):553-563.DOI:10.1016/j.rcl.2015.12.005.
[4] 陈欣媛,李智.儿童炎性肌纤维母细胞瘤诊治进展[J].临床小儿外科杂志,2023,22(3):296-300.DOI:10.3760/cma.j.cn101785-202204073-018.Chen XY,Li Z.Updates in diagnosis and treatment of inflammatory myofibroblastic tumor in children[J].J Clin Ped Sur,2023,22(3):296-300.DOI:10.3760/cma.j.cn101785-202204073-018.
[5] Jo VY,Fletcher CDM.WHO classification of soft tissue tumours:an update based on the 2013(4th) edition[J].Pathology,2014,46(2):95-104.DOI:10.1097/PAT.0000000000000050.
[6] Li YP,Han WW,He LJ,et al.Inflammatory myofibroblastic tumor after treatment of Wilms tumor in a 6-year-old boy:a case report and literature review[J].Urology,2021,149:e25-e28.DOI:10.1016/j.urology.2020.11.012.
[7] DongYH,Zahid KR,Han YD,et al.Treatment of pediatric inflammatory myofibroblastic tumor:the experience from China Children’s Medical Center[J].Children (Basel),2022,9(3):307.DOI:10.3390/children9030307.
[8] Sbaraglia M,Bellan E,Dei Tos AP.The 2020 WHO classification of soft tissue tumours:news and perspectives[J].Pathologica,2021,113(2):70-84.DOI:10.32074/1591-951X-213.
[9] Anderson WJ,Doyle LA.Updates from the 2020 World Health Organization classification of soft tissue and bone tumours[J].Histopathology,2021,78(5):644-657.DOI:10.1111/his.14265.
[10] 胡嘉健,黄一晋,韩建宇,等.小儿腹部炎性肌纤维母细胞瘤诊治探讨[J].临床小儿外科杂志,2020,19(4):336-341.DOI:10.3969/j.issn.1671-6353.2020.04.011.Hu JJ,Huang YJ,Han JY,et al.Abdominal inflammatory myofibroblastic tumors in children:a clinical diagnosis and treatment review[J].J Clin Ped Sur,2020,19(4):336-341.DOI:10.3969/j.issn.1671-6353.2020.04.011.
[11] Torres US,Matsumoto C,Maia DR,et al.Computed tomography and magnetic resonance imaging findings of inflammatory pseudotumors in the abdomen and pelvis:current concepts and pictorial review[J].Semin Ultrasound CT MR,2018,39(2):220-229.DOI:10.1053/j.sult.2017.09.005.
[12] Liu B,Xu JL,Wang JX,et al.Computed tomography appearance of inflammatory myofibroblastic tumor in the abdomen:CT features and pathologic correlation[J].Int J Clin Exp Med,2015,8(9):16745-16755.
[13] Bennett JA,Nardi V,Rouzbahman M,et al.Inflammatory myofibroblastic tumor of the uterus:a clinicopathological,immunohistochemical,and molecular analysis of 13 cases highlighting their broad morphologic spectrum[J].Mod Pathol,2017,30(10):1489-1503.DOI:10.1038/modpathol.2017.69.
[14] Devereaux KA,Fitzpatrick MB,Hartinger S,et al.Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions[J].Am J Surg Pathol,2020,44(7):970-981.DOI:10.1097/PAS.0000000000001481.
[15] Chan JK,Cheuk W,Shimizu M.Anaplastic lymphoma kinase expression in inflammatory pseudotumors[J].Am J Surg Pathol,2001,25(6):761-768.DOI:10.1097/00000478-200106000-00007.
[16] Coffin CM,Hornick JL,Fletcher CDM.Inflammatory myofibroblastic tumor:comparison of clinicopathologic,histologic,and immunohistochemical features including ALK expression in atypical and aggressive cases[J].Am J Surg Pathol,2007,31(4):509-520.DOI:10.1097/01.pas.0000213393.57322.c7.
[17] Nakano K.Inflammatory myofibroblastic tumors:recent progress and future of targeted therapy[J].Jpn J Clin Oncol,2023,53(10):885-892.DOI:10.1093/jjco/hyad074.
[18] Zhu Y,Ding Y,Song GX,et al.Clinicopathological features of inflammatory myofibroblastic tumor[J].Chin J Pathol,2021,50(3):194-200.DOI:10.3760/cma.j.cn112151-20200806-00627.
[19] Siemion K,Reszec-Gielazyn J,Kisluk J,et al.What do we know about inflammatory myofibroblastic tumors?-A systematic review[J].Adv Med Sci,2022,67(1):129-138.DOI:10.1016/j.advms.2022.02.002.
[20] Preobrazhenskaya EV,Suleymanova AM,Bizin IV,et al.Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours[J].Histopathology,2023,83(1):109-115.DOI:10.1111/his.14912.
[21] Biswas R,Halder A,Gangopadhyay M,et al.Inflammatory myofibroblastic tumor of maxillary sinus successfully treated with radiotherapy and corticosteroid:report of a rare case[J].J Egypt Natl Canc Inst,2020,32(1):26.DOI:10.1186/s43046-020-00038-0.
[22] Casanova M,Brennan B,Alaggio R,et al.Inflammatory myofibroblastic tumor:The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)[J].Eur J Cancer,2020,127:123-129.DOI:10.1016/j.ejca.2019.12.021.
[23] Panigada S,Sacco O,Girosi D,et al.Corticosteroids may favor proliferation of thoracic inflammatory myofibroblastic tumors[J].Pediatr Pulmonol,2014,49(3):E109-E111.DOI:10.1002/ppul.22977.
[24] Butrynski JE,D’Adamo DR,Hornick JL,et al.Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor[J].N Engl J Med,2010,363(18):1727-1733.DOI:10.1056/NEJMoa1007056.
[25] Trahair T,Gifford AJ,Fordham A,et al.Crizotinib and surgery for long-term disease control in children and adolescents with ALK-positive inflammatory myofibroblastic tumors[J].JCO Precis Oncol,2019,3:1-11.DOI:10.1200/PO.18.00297.
[26] Mansfield AS,Murphy SJ,Harris FR,et al.Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib[J].Ann Oncol,2016,27(11):2111-2117.DOI:10.1093/annonc/mdw405.
[27] Mittal A,Gupta A,Rastogi S,et al.Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour[J].Ecancermedicalscience,2021,15:1215.DOI:10.3332/ecancer.2021.1215.
[28] Cottrell TR,Duong AT,Gocke CD,et al.PD-L1 expression in inflammatory myofibroblastic tumors[J].Mod Pathol,2018,31(7):1155-1163.DOI:10.1038/s41379-018-0034-6.
[29] Fordham AM,Xie JH,Gifford AJ,et al.CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma[J].Br J Cancer,2020,123(7):1101-1113.DOI:10.1038/s41416-020-0996-2.
相似文献/References:
[1]匡玉婷 赵斯君 李 赟.鼻内镜下电动吸割器治疗小儿喉乳头状瘤临床分析[J].临床小儿外科杂志,2010,9(04):0.
[2]邹华新,刘铭.Rb和P21基因在婴幼儿皮肤血管瘤中的表达及意义[J].临床小儿外科杂志,2008,7(04):0.
[3]刘洲禄,肖元宏,陈迪祥,等.儿童腹膜后肿瘤累及重要血管的手术处理[J].临床小儿外科杂志,2008,7(06):4.
[4]吕然博. 小脑延髓裂入路手术切除儿童第四脑室肿瘤[J].临床小儿外科杂志,2011,10(03):196.
[J].Journal of Clinical Pediatric Surgery,2011,10(02):196.
[5]李长春 王珊 章均 欧阳军 孔祥如 杨超 赵珍珍 吕麟亚. B超引导下芯针穿刺活检术诊断儿童实体肿瘤的临床分析[J].临床小儿外科杂志,2011,10(04):247.
[J].Journal of Clinical Pediatric Surgery,2011,10(02):247.
[6]刘菁 张晓伦 包楠 李龙 陈晓波. 小儿恶性肿瘤合并抗利尿激素分泌失调综合征3例[J].临床小儿外科杂志,2011,10(04):312.
[J].Journal of Clinical Pediatric Surgery,2011,10(02):312.
[7]殷敏智 陈其民 张忠德 马 靖 吴湘如 施诚仁.儿童胸部炎性肌纤维母细胞瘤的临床病理探讨[J].临床小儿外科杂志,2013,12(02):97.[doi:10.3969/j.issn.1671— 6353.2013.02.006]
YIN Min-zhi,CHEN Qi-min,ZHANG Zhong-de,et al.he analysis of paediatric inflammatory myofibroblastic tumor’s clinicopathological features,lectures review[J].Journal of Clinical Pediatric Surgery,2013,12(02):97.[doi:10.3969/j.issn.1671— 6353.2013.02.006]
[8]赵瑞,周渊峰,杨皓玮,等.儿童颞叶癫痫的临床特点及手术疗效分析[J].临床小儿外科杂志,2018,17(04):269.
Zhao Rui,Zhou Yuanfeng,Yang Haowei,et al.Clinical characteristics and surgical treatment of temporal lobe epilepsy in children.[J].Journal of Clinical Pediatric Surgery,2018,17(02):269.
[9]侯培民,王东明,张强业,等.腔镜技术在小儿肿瘤切除手术中的应用及技巧探讨[J].临床小儿外科杂志,2019,18(04):277.[doi:10.3969/j.issn.1671-6353.2019.04.006]
Hou Peimin,Wang Dongming,Zhang Qiangye,et al.Application and skill exploration of laparoscopic and thoracoscopic technology in pediatric tumor resection[J].Journal of Clinical Pediatric Surgery,2019,18(02):277.[doi:10.3969/j.issn.1671-6353.2019.04.006]
[10]郭强,张伟,朱丹.儿童致痫性低级别肿瘤的手术策略与切除范围设计[J].临床小儿外科杂志,2019,18(09):719.[doi:10.3969/j.issn.1671-6353.2019.09.002]
Guo Qiang,Zhang Wei,Zhu Dan.Surgical strategies and scope of resecting epileptic low-grade tumors in children[J].Journal of Clinical Pediatric Surgery,2019,18(02):719.[doi:10.3969/j.issn.1671-6353.2019.09.002]
备注/Memo
收稿日期:2023-8-16。
基金项目:湖南省卫生健康委科研计划课题(202104081314);湖南省自然科学基金-面上项目(2023JJ30323)
通讯作者:李勇,Email:liyongpuwaike@163.com